VRS
CHRS icon

Virginia Retirement Systems’s Coherus Oncology CHRS Stock Holding History

Virginia Retirement Systems’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-16,200
Closed -$128K – 1064
2022
Q4 		$128K Sell
16,200
-5,500
-25% -$42.3K ﹤0.01% 1084
2022
Q3 		$209K Buy
+21,700
New +$220K ﹤0.01% 1052
2022
Q1 		$148K Sell
11,500
-14,000
-55% -$178K ﹤0.01% 1072
2021
Q4 		$407 Sell
25,500
-38,100
-60% -$666K ﹤0.01% 907
2021
Q3 		$1.02M Sell
63,600
-23,700
-27% -$347K 0.01% 595
2021
Q2 		$1.21M Buy
87,300
+10,100
+13% +$143K 0.01% 577
2021
Q1 		$1.13M Buy
77,200
+36,700
+91% +$623K 0.01% 609
2020
Q4 		$704K Sell
40,500
-8,400
-17% -$150K 0.01% 727
2020
Q3 		$897K Sell
48,900
-6,500
-12% -$121K 0.01% 572
2020
Q2 		$989K Buy
55,400
+3,800
+7% +$64.3K 0.01% 562
2020
Q1 		$837K Sell
51,600
-12,900
-20% -$238K 0.01% 617
2019
Q4 		$1.16M Buy
64,500
+23,400
+57% +$432K 0.01% 629
2019
Q3 		$833K Buy
+41,100
New +$821K 0.01% 747

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Virginia Retirement Systems's CHRS Position: Q1 2023 in Review

Virginia Retirement Systems sold out of Coherus Oncology (CHRS) in Q1 2023, closing a stake of 16,200 shares — an estimated $128K sold.

Virginia Retirement Systems first reported a position in CHRS in Q3 2019 and held it in 13 quarters. The position peaked at $1.21M in Q2 2021. 163 funds tracked by Wall St. Rank hold CHRS as of Q1 2023.

  • Virginia Retirement Systems reported no remaining Coherus Oncology position as of Q1 2023 after selling out during the quarter.
  • Virginia Retirement Systems sold 16,200 Coherus Oncology shares in Q1 2023, an estimated $128K.
  • Virginia Retirement Systems first reported a position in Coherus Oncology in Q3 2019 and held it in 13 quarters.
  • Virginia Retirement Systems's Coherus Oncology position peaked at $1.21M in Q2 2021.
  • 163 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2023.

Based on Virginia Retirement Systems's 13F filing for Q1 2023, filed 11 Jul 2023.